Delivery Order SPE2DB20D2104-SPE2DB23FV04P

Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,749,486 units of Naloxone HCL 4 mg Nasal Spray. The firm-fixed-price delivery order has a ceiling value of $2,086.45 and a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 through...
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,271.05, is for the delivery of 4,562,300 units of Naloxone HCL 4 mg nasal spray. This is a Firm Fixed Price Delivery Order contract that runs through September 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,367,200 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,950.71 and an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,357.92, is a delivery order to provide 4,565,123,305 units of the drug Naloxone HCL 4 mg Nasal Spray. The contract has an ultimate completion date of July 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,960,168 units of Naloxone HCl 4 mg nasal spray. The firm-fixed-price contract, valued at $3,088.40, has a completion date of June 21, 2024. AmerisourceBergen, a major pharmaceutical distribution company, has extensive experience fulfilling government contracts for a wide range of medical products, including prescription medications,...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of 4,563,955,933 units of Naloxone HCl 4 mg Nasal Spray in 2-count packages, with a total ceiling value of $5,637.45 and an ultimate completion date of March 14, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award, valued at $7,744.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,861,499 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,093.98 firm fixed-price delivery order is for the supply of 4,561,231,931 units of naloxone HCl 4 mg nasal spray. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.32 Firm Fixed Price delivery order covers the supply of 4,561,769,383 units of Naloxone HCl 4 mg Nasal Spray, with an ultimate completion date of August 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV04P
    Delivery Order

This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. is a Delivery Order (SPE2DB23FV04P) valued at $1,494.12 for the procurement of 4,561,936,958 units of Naloxone HCL 4 mg Nasal Spray. The contract has an ultimate completion date of August 25, 2023 and was awarded on August 24, 2023. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order falls under the larger IDC framework. The contract was awarded on an unrestricted basis, with no set-aside designation.

Generated 2/27/25, 10:19 AM